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In summer 2008, a 73-year-old man
arrived in the emergency room with vague
abdominal pain. On examination, his
abdomen was distended and tympanic,
but soft and non-tender on palpation. The
patient had been immobile and bed-
ridden since 1995, when he had neuro-
surgical resection of a medullary ependy-
moma of the spine, with residual paraple-
gia, peripheral neuropathy, and a
neuropathic bladder with secondary
chronic renal failure. The patient had a
medical history of hypertension and type
II diabetes mellitus and suffered from
chronic constipation with recurrent epi-
sodes of partial bowel obstruction.
Given his past history, the current
presentation was in keeping with a further
episode of bowel obstruction. At this stage,
we needed to assess the degree of obstruc-
tion (complete or partial) and its possible
causes.
What Investigations Are
Required in Assessing Bowel
Obstruction?
The full diagnostic workup is shown in
Box 1, and Figure 1 shows a flow diagram
for diagnostic assessment of bowel ob-
struction. The usual sequence of investi-
gations starts with plain abdominal X-ray
(see Figure 1). In the absence of grossly
distended bowel loops on X-ray, and if the
patient’s condition is stable, ultrasound
can be useful to rule out (1) other
conditions or diseases causing paralytic
ileus or (2) the presence of intraperitoneal
free fluid. If the plain abdominal X-ray
shows air fluid levels and grossly distended
bowel loops, the level and possible site of
obstruction must be assessed (i.e., small
bowel or large bowel), and the further
diagnostic workup proceeds accordingly.
When in doubt, or when the clinical and
radiological findings are not clear enough
to suggest the best further diagnostic steps,
abdominal computed tomography (CT)
scan may be helpful, with the eventual
adjunct of triple contrast (intravenous,
oral, and/or rectal). The last diagnostic
options are diagnostic laparoscopy or
exploratory laparotomy.
Plain abdominal X-ray was ordered.
This showed a huge faecal impaction
extending from the pelvis upwards to the
left subphrenic space and from the left
towards the right flank, measuring over
40 cm in length and 33 cm in width
(Figure 2). There was also massive dilata-
tion of the descending and sigmoid colon.
At This Stage, What Was Our
Differential Diagnosis?
This patient has partial large bowel
obstruction. The differential diagnosis is
between malignant obstructing diseases,
such as colon cancer, or benign conditions,
such as sigmoid volvulus or diverticulitis.
The Learning Forum discusses an important clinical
problem of relevance to a general medical audience.
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Box 1. Intestinal Obstruction: Diagnostic Workup
N Supine and erect plain abdominal X-ray
N Abdominal ultrasound (this is of limited value in bowel obstruction and/or in
patients with distended bowel because the air, limiting ultrasound transmis-
sion, may obscure and camouflage the underlying findings)
N CT scan
N Conventional barium follow-through examination, upper gastrointestinal and
small bowel series, enteroclysis (fluoroscopic X-ray of the small intestine) [18]
N Water-soluble contrast follow-through (this investigation is safer than barium in
cases of perforation and peritoneal spread and has possible therapeutic value in
the case of adhesive small intestine obstruction [19])
N Contrast (barium or water-soluble) enema
N CT scan with double contrast (intravenous and oral or rectal)
N Magnetic resonance imaging
N Endoscopy (colonoscopy, esophagogastroduodenoscopy, ileoscopy)
N Laparoscopy
PLoS Medicine | www.plosmedicine.org 1 July 2009 | Volume 6 | Issue 7 | e1000092Figure 1. Flow diagram for diagnostic assessment of bowel obstruction. ASBO, adhesive small bowel obstruction; EGDS,
esophagogastroduodenoscopy; GI: gastrointestinal; i.v., intravenous; SBO, small bowel obstruction.
doi:10.1371/journal.pmed.1000092.g001
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threatening because of the risk of colonic
ischaemia and/or perforation.
Given the history of recurrent chronic
constipation, in a chronically bed-ridden
patient with previous spinal surgery and
residual paraplegia, we thought it was
likely that this patient had faecal impac-
tion without an anatomical lesion causing
the impaction. Pinpointing the exact cause
of the constipation in this patient was
difficult, as he had a complex medical
history and presentation—renal failure,
dehydration, electrolyte imbalance, diabe-
tes mellitus, and peripheral neuropathy
and paraplegia secondary to spinal cord
tumour, in an immobile bed-ridden pa-
tient with mild depression. Common
causes of constipation are shown in Box
2. Some of the causal and contributing
factors for constipation in patients under-
going palliative care are shown in Box 3.
What Measures Could Prevent
or Correct the Factors
Exacerbating Chronic
Constipation in Patients
Receiving Palliative Care?
In patients receiving palliative care, the
underlying causal factors for constipation
are likely to be long-standing. The patient’s
bowel pattern needs to be carefully assess-
ed, with a focus on looking for modifiable
factors. For example, if a particular phar-
macological agent is identified as a possible
causativefactor,itmaybehelpfultochange
the agent or the route of its administration.
It is also helpful to anticipate the constipat-
ing effects of medications, such as opioids,
and to provide laxatives prophylactically.
Other concomitant or contributing factors
such as electrolyte imbalances or metabol-
Figure 2. Initial plain abdominal X-ray done in emergency room showing a huge
faecal impaction extending from the pelvis upwards to the left subphrenic space and
from the left towards the right flank, measuring over 40 cm in length and 33 cm in
width.
doi:10.1371/journal.pmed.1000092.g002
Box 2. Causes of Constipation
N Endocrinological: diabetes mellitus, hypopituitarism, hypothyroidism, pseudohypoparathyroidism, hypocalcaemia,
phaeochromocytoma, glucagonoma, pregnancy
N Metabolic: uraemia, hypokalaemia, porphyria, amyloidosis, dehydration
N Neurological: Parkinson disease, brain tumour, multiple sclerosis, sclerodermia, spinal cord injuries, tumours
N Psychiatric: depression, psychosis, anorexia nervosa, obsessive-compulsive disorders
N Operations: pelvic operations, anal operations, narrowing following anastomoses
N Organic obstructive diseases: tumours, adherences, strangulated hernias, volvulus, invagination, endometriosis
N Diet: inadequate intake of fibre or fluids
N Lifestyle changes: immobility, vacation
N Functional diseases: functional obstructive bowel diseases, congenital or acquired aganglionosis, Ogilvie syndrome,
megacolon, irritable bowel disease
N Pelvic exit obstruction: rectal prolapse, rectocele, rectal intussusception, rectal stenosis, megarectum, hypertonus of
internal sphincter, paradoxical contraction of puborectal muscle
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tified and corrected. However, the under-
lying cause of constipation is often unavoid-
able and pharmacological treatment is
often necessary [1].
In this patient, a long colonic-rectal
tube was inserted with partial relief of the
abdominal distension after expulsion of
8,000 ml of gas. The patient was admitted
to the medical ward for rehydration,
correction of electrolyte imbalance, and
multiple enemas. Two days later the faecal
impaction, although slightly reduced, still
measured 32 cm in length and 24 cm in
width (Figure 3). After ten days of
conservative treatment, the abdomen re-
mained visibly distended (Figure 4).
Which Diagnostic Exam Would
Now Be Helpful?
Serial plain abdominal X-rays had
already been performed. Colonoscopy
was not feasible, because the severe faecal
impaction may have hindered the pro-
gression of the endoscope and affected the
sensitivity of the exam by covering and
camouflaging possible mucosal lesions of
the colonic wall. Contrast enema would
probably not have been effective or
diagnostic. Therefore abdominal CT scan
with multiplanar reconstruction and three-
dimensional (3-D) reconstruction ap-
peared to be the best option as a further
diagnostic step, in order to assess the
presence of an anatomic cause for the
patient’s bowel obstruction.
Abdominal CT scan was ordered. The
multiplanar and 3-D reconstruction
showed the persistence of a large faecal
impaction, over 18 cm in extent (Figure 5),
in the sigmoid colon. There was massive
Box 3. Causal and/or Contributing Factors to Constipation in Patients in Palliative Care (Modified
from [20])
Organic Factors
N Pharmacological agents: antacids, antiepileptics, antiemetics (5-HT3 antagonists), antihypertensives, antiparkinsonians,
anticholinergics, antidepressants, antitussives, antidiarrheals (by causing dehydration), cancer chemotherapy agents, diuretics
(by causing dehydration), iron (orally administered), opioid analgesics, neuroleptics
N Metabolic abnormalities: dehydration (fever, vomiting, polyuria, poor fluid intake, diuretics), hypercalcaemia,
hypokalaemia, uraemia, hypothyroidism, diabetes
N Neurological disorders: spinal cord involvement, sacral nerve infiltration, autonomic failure (Parkinson disease, multiple
sclerosis, motor neurone disease, diabetic neuropathy)
N Painful anorectal conditions (haemorrhoids, anal fissure, perianal abscess)
Functional Factors
N Diet: Poor appetite and low amounts of food intake, low-fibre diet, poor fluid intake
N Environmental: Lack of privacy, comfort, or assistance with toileting
N Other factors: Advanced age, inactivity, decreased mobility, bed-ridden patients, depression, sedation
Figure 3. Plain abdominal X-ray after two days of medical treatment (rehydration,
correction of electrolyte imbalance, and multiple enemas) showing enormous faecal
impaction, although slightly reduced, still measuring 32 cm in length and 24 cm in
width.
doi:10.1371/journal.pmed.1000092.g003
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of the descending sigmoid colon.
It is likely that the abnormally dilated
descending colon was exacerbating the
neurogenic chronic faecal stagnation
(Figure 6).
What Was the Next Step in
Managing This Condition?
Rehydration, multiple enemas, the pro-
kinetic agent neostigmine (see Box 4), and
laxatives were continued with gradual
relief of the bowel obstruction and resolu-
tion of the faecal impaction.
We believed that neostigmine, which
has a focused effect in stimulating large
bowel motility, was the most appropriate
and beneficial prokinetic agent in this
setting (it is also appropriate in patients
with colonic pseudo-obstruction).
The patient was scheduled for elective
surgical resection of the redundant mega-
colon. He was discharged 25 days after
admission, after rehydration, multiple
enemas, prokinetic agents, and laxatives.
On discharge, the abdomen remained
slightly distended but was soft and non-
tender. The patient was passing stools and
not vomiting. We suggested home nursing
to the patient and his family.
After discharge, he underwent elective
surgical resection of the redundant megaco-
Figure 4. Clinical view of the abdomen, still grossly distended after ten days of
conservative treatment.
doi:10.1371/journal.pmed.1000092.g004
Figure 5. Abdominal CT scan with multiplanar reconstruction showing the persistence of a large faecal impaction, over 18 cm in
extent, located in the sigmoid colon, as well as a massive dilatation of the colonic wall and the descending sigmoid colon forming a
twisting loop.
doi:10.1371/journal.pmed.1000092.g005
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he had an uneventful postoperative course.
The patient gave written consent for
these case details to be published.
Discussion
If people in Western societies continue
to live longer, we are likely to see an
increase in the number of institutionalised
elderly people with impaired mobility.
Both ageing and immobility are risk
factors for constipation. The estimated
prevalence of constipation is between
2%–28%, and the number of people
reporting constipation increases with age
[2–4]. Constipation is more severe in those
with pre-existing neurological illness and
injury [5,6]. A US study found that
constipation was more common in wom-
en, African Americans, people from lower
socioeconomic levels, and those living in
rural areas and northern states [7]. Faecal
impaction is common in frail ill elderly
people or in people of any age if they have
a neurologic impairment (e.g., spinal cord
injury, stroke, multiple sclerosis, spina
bifida).
The prevalence of constipation among
patients in palliative care ranges from 32%
to 87%, and it is particularly common in
patients with end-stage cancer [8–10]. The
combination of physical illness and hospi-
talisation may cause and/or worsen con-
stipation. About 50% of patients admitted
to hospices cite constipation as a main
concern [11], and this is the third most
common symptom after pain and anorexia
in patients in hospices.
Complications of Constipation
In severe constipation, patients are
usually unable to pass much stool and
may pass only small amounts of watery
stool. They typically experience abdomi-
nal pain, discomfort and bloating, and
may also lose their appetite. Some very ill
older patients may have a change in
behaviour and may develop fever.
In patients with constipation associated
with a sigmoid redundant megacolon,
colonic volvulus can develop, with possible
progression to bowel wall ischaemia and
perforation. Early surgical consultation
and laparotomy are mandatory in such
cases.
Treatment of Constipation
Treatment of constipation, and of the
most severe forms of faecal impaction, is
multimodal [12]. If a large impaction is
present, it may need to be broken up
manually, using lubricated gloved fingers
with patients lying on their left side [13].
Figure 6. Multiplanar and 3-D reconstruction CT scan showed abnormally dilated
descending colon and tortuous twisting loop, worsening the neurogenic chronic
faecal stagnation.
doi:10.1371/journal.pmed.1000092.g006
Box 4. Prokinetic Agents for Gastrointestinal Motility Disorders
[21,22]
N Cholinergic agents (bethanechol): indications: postoperative ileus; limita-
tions: side effects
N Dopamine antagonists (domperidone): indications: gastroparesis and
gastroesophageal reflux; limitations: poorly effective in colonic motility
disorders
N Opioid antagonists (naloxone): indications: irritable bowel syndrome, small
intestinal pseudo-obstruction, constipation
N Motilin agonists (erythromycin): indications: diabetic gastroparesis, colonic
pseudo-obstruction, postoperative ileus
N Cholinergic agonist and dopamine antagonist (metoclopramide):
indications: exclusively for proximal motility dysfunction
N Parasympathomimetics (cisapride): indications: colonic motility disorders,
constipation-predominant irritable bowel syndrome
N Partial serotonin agonist (tegaserod): indications: constipation-predomi-
nant irritable bowel syndrome; limitations: cardiovascular adverse effects
N Acetylcholine esterase inhibitor (neostigmine): indications: colonic
pseudo-obstruction
N Prostaglandins: lubiprostone (prostaglandin E1 derivative) and oral prosta-
glandin E2 are reported to increase small intestine and colonic transit
N Cholecystokinin antagonist (ceruletide): enhances gastrointestinal motility
N Analogue of somatostatin (octreotide): experimental evidence of short-
ening ileus and promoting bowel movements in the small intestine and colon
in animal models
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and soapsuds [14], or even with natural
mixtures such as milk and molasses, can
contribute to removing any leftover stool
(a clinical trial of a milk and molasses
enema for childhood constipation is un-
derway in the US; see http://clinicaltrials.
gov/ct2/show/NCT00467350). Fibres
and laxatives can increase stool frequency
and improve symptoms of constipation
[15]. Pulsed irrigation of faecal impaction
is also used for bowel management in
patients with chronic constipation. It has
been used primarily in patients with
neuropathic bowel who have failed con-
servative therapy. Hospitalisation for re-
hydration and electrolyte imbalance cor-
rection is required for some patients, and
in the most severe cases manual disimpac-
tion under general anaesthesia is required
[16].
Diagnostic assessment for colonic dis-
eases is not routinely required. Such
assessment is usually reserved for patients
whose constipation is refractory to conser-
vative treatment, or who have persistent
severe faecal impaction, and/or who are
found to have concomitant colonic ob-
structive disease.
Management of chronic constipation is
shown in Box 5. The different levels and
steps in managing chronic constipation
should be focused on the different under-
lying conditions and needs of patients.
Management is primarily conservative for
patients with mild long-term constipation,
in younger patients, and in those who are
otherwise healthy and will adhere to a
conservative regime. Medical treatment
should be initiated for moderate-to-severe
constipation, in the elderly, institutional-
ised, critically ill, or neurologically im-
paired, and in patients in palliative care
and who are at the end of their lives.
Surgical treatment should be reserved for
selected patients (see Box 5) and/or
constipation that is persistent and unre-
sponsive to the other treatments.
Managing Constipation in Palliative
Care
In palliative care, nursing staff play a
crucial role in the assessment, prophylaxis,
and management of constipation, since
they are in daily contact with patients.
Such assessments should focus not only on
the frequency of bowel movements, but
also on the quality of stools; length of time
to defecation; diarrhoea and overflow
diarrhoea; continence and incontinence;
effectiveness of laxatives; addition of
complementary therapies worsening con-
stipation; diet and fluid intake; environ-
mental factors that could be influencing
Box 5. Management of Chronic Constipation
1.Conservative (for mild constipation, younger patients, those who are
otherwise healthy and will adhere to a conservative regime)
N lifestyle modification (adequate intake of dietary fibre and fluids, regular
physical activity)
N behavioural approaches (habit training, biofeedback)
N bowel training
2.Medical (for moderate-to-severe constipation, elderly, institutional-
ised, critically ill, or neurologically impaired patients, or patients in
palliative care settings)
N Oral laxatives
# Predominantly softening:
& Faecal lubricants: liquid paraffin
& Bulk-forming laxatives: methylcellulose, polycarbophil, psyllium, ispa-
gula
& Macrogols: polyethylene glycol and electrolytes
& Osmotic hyperosmolar laxatives: lactulose, sorbitol
& Emollient stool softeners and surfactants: docusate calcium, docusate
sodium
& Saline laxatives: magnesium citrate, magnesium hydroxide, magnesium
sulphate, sodium biphosphate
# Combination laxatives:
& Softener and stimulant: poloxamer and dantron
# Predominantly peristalsis-stimulating:
& Anthraquinones: senna, danthron, cascara sagrada
& Polyphenolics and other stimulant laxatives: bisacodyl, sodium picosul-
phate, castor oil
N Rectal laxatives
# Predominantly softening:
& Faecal lubricants: arachis oil enema, docusate sodium enema
& Osmotic laxatives: glycerol suppository
& Saline laxatives: phosphate enema, sodium citrate enema
# Predominantly stimulating:
& Polyphenolics: bisacodyl suppository
N Prokinetics drugs (see Box 4)
N Injection of botulinum toxin
3.Surgical (for selected patients)
N Repair of non-emptying rectoceles for patients with obstructed defecation
N Subtotal colectomy with ileorectal anastomosis for patients with persistent
and intractable slow transit constipation
N Patients with combined slow transit constipation and pelvic outlet
obstruction, as well as symptomatic refractory retaining rectoceles and rectal
intussusception, benefit from subtotal colectomy with ileorectal anastomosis
and repair or treatment of the outlet obstruction causing pathology
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vacy); and the need for abdominal mas-
sage. Abdominal massage, performed by a
massage therapist, may be used in patients
with chronic constipation and altered
motility as an adjunctive measure; it may
help to stimulate the periphery of the small
and large intestines and relieve bowel
atony. A recent randomised controlled
trial of abdominal massage plus laxatives
versus laxatives alone for constipation
found that the addition of massage was
associated with decreased constipation and
abdominal pain and increased bowel
frequency [17].
Larkin and colleagues recently pub-
lished an algorithm on prophylaxis, ongo-
ing assessment, and treatment of constipa-
tion in palliative care settings [1]. Ongoing
monitoring for early symptoms of consti-
pation and patient education are the
cornerstones of prophylaxis. The first step
in treatment should be a careful assess-
ment to confirm constipation and exclude
malignant causes of intestinal obstruction.
The next step is the identification and
treatment of correctable causes. If the
cause is not correctable, first-line treat-
ment should be with oral laxatives (a
combination of softener and stimulants
according to patient needs [1]). If this
treatment improves symptoms, it should
be continued; otherwise a second-line
treatment should be adopted. Standard
second-line treatment is a rectal supposi-
tory and enema. If first-line and second-
line treatments fail, the third-line treat-
ment is manual evacuation. During sec-
ond-line and third-line treatment, adding
a peripheral opioid antagonist may be
helpful if the patient is taking opioids.
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Key Learning Points
N Older patients, institutionalised elderly people, and chronically bed-ridden
patients commonly experience constipation and are at risk of developing
severe fecal impaction.
N This risk is higher in the presence of neurological illnesses or injuries.
N The management is usually conservative and multimodal.
N The combination of a softener and stimulant laxative is generally recommend-
ed, and the choice of laxatives should be made on an individual basis.
N Diagnostic assessment for colonic diseases and surgical consultation are not
routinely required.
N Unsuccessful conservative treatment, the persistence of severe faecal impac-
tion, and/or the finding of concomitant colonic obstructive disease should lead
to further diagnostic assessment and surgical consultation.
N Early surgical consultation and urgent laparotomy are required in the case of
free air on plain abdominal X-ray and/or signs of peritonism and acute
abdomen.
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